DuraHeart™ magnetically levitated left ventricular assist device - Osaka university experience

Circulation Journal

Volumn 77, Issue 7, 2013, Pages 1736-1741

  Sakaguchi, Taichi ^a   Matsumiya, Goro ^b   Yoshioka, Daisuke ^a   Miyagawa, Shigeru ^a   Nishi, Hiroyuki ^a   Yoshikawa, Yasushi ^a   Fukushima, Satsuki ^a   Saito, Shunsuke ^a   Ueno, Takayoshi ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Transplantation; Ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEPARIN; LACTATE DEHYDROGENASE; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; AORTA VALVE REGURGITATION; ARTICLE; ASSISTED CIRCULATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DISEASE REGISTRY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INFECTION; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; LIVER FUNCTION; LONG TERM SURVIVAL; MALE; PROSTHESIS FAILURE; PROTHROMBIN TIME; QUALITY OF LIFE; RECURRENT INFECTION; SURVIVAL RATE; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; FOLLOW-UP STUDIES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MAGNETICS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; QUALITY OF LIFE;

EID: 84879406597     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-1410     Document Type: Article

References (26)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
2. Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003; 9: 180-187.
3. Saito S, Matsumiya G, Sakaguchi T, Fujita T, Kuratani T, Ichikawa H, et al. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs 2009; 12: 27-34.
4. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
5. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251.
6. Yoshitake I, El-banayosy A, Yoda M, Hata M, Sezai A, Niino T, et al. First clinical application of the DuraHeart centrifugal ventricular assist device for a Japanese patient. Artif Organs 2009; 33: 763-766.
7. R support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs 2011; 14: 67-69.
8. Morshuis M, El-Banayosy A, Arusoglu L, Koerfer R, Hetzer R, Wieselthaler G, et al. European experience of DuraHeartTM magnetically levitated centrifugal left ventricular assist system. Eur J Cardiothorac Surg 2009; 35: 1020-1028.
9. Nishinaka T, Schima H, Roethy W, Rajak A, Nojiri C, Wolner E, et al. The DuraHeart VAD, a magnetically levitated centrifugal pump: The University of Vienna bridge-to-transplant experience. Circ J 2006; 70: 1421-1425.
10. Saito S, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, Ueno T, et al. Biventricular support using implantable continuous-flow ventricular assist devices. J Heart Lung Transplant 2011; 30: 475-478.
11. Komoda T, Weng Y, Nojiri C, Hetzer R. Implantation technique for the DuraHeart left ventricular assist system. J Artif Organs 2007; 10: 124-127.
12. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, et al. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J 2012; 76: 372-376.
13. Kawamura M, Sakaguchi T, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, et al. Exchange of DuraHeart left ventricular assist device via a subcostal approach. J Artif Organs 2012; 15: 87-89.
14. Morshuis M, Shoenbrodt M, Nojiri C, Roefe D, Schulte-Eistrup S, Boergermann J, et al. DuraHeartTM magnetically levitated centrifugal left ventricular assist sytem for advanced heart failure patients. Expert Rev Med Devices 2010; 7: 173-183.
15. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U.S. Food and Drug Administration approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS. J Am Coll Cardiol 2011; 57: 1890-1898.
16. Saito S, Sakaguchi T, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, et al. Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure. J Heart Lung Transplant 2012; 31: 858-864.
17. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device implantation: Significance of INTERMACS level and renal function. Circ J 2012; 76: 1631-1638.
18. Kinugawa K. How to treat stage D heart failure?: When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J 2011; 75: 2038-2045.
19. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J 2013; 77: 96-104.
20. Aggarwal A, Raghuvir R, Eryazici P, Macaluso G, Sharma P, Blair C, et al. The development of aortic insufficiency in continuous-flow left ventricular assist device-supported patients. Ann Thorac Surg 2013; 95: 493-498.
21. Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 2011; 75: 1147-1155.
22. Toda K, Fujita T, Domae K, Shimahara Y, Kobayashi J, Nakatani T. Late aortic insufficiency related to poor prognosis during left ventricular assist device support. Ann Thorac Surg 2011; 92: 929-934.
23. Milano CA, Simeone AA, Blue LJ, Rogers JG. Presentation and management of left ventricular assist device inflow cannula malposition. J Heart Lung Transplant 2011; 30: 838-840.
24. Bolen MA, Popovic ZB, Gonzalez-Stawinski G, Schoenhagen P. Left ventricular assist device malposition interrogated by 4-D cine computed tomography. J Cardiovasc Comput Tomogr 2011; 5: 186-188.
25. Paluszkiewicz L, Schulte-Eistrup S, Gummert J, Koertke H. Asymptomatic displacement of the inflow cannula of a patient 18 months after implantation of a DuraHeart left ventricular assist device. J Am Coll Cardiol 2011; 58: 1516.
26. Woo YJ, Acker MA. Implantable ventricular assist device exchange with focused intravascular deairing techniques. Ann Thorac Surg 2011; 91: 306-307.